C. Barrow, J. Browning, D. Macgregor, I. D. Davis, S. Sturrock et al., Tumor antigen expression in melanoma varies according to antigen and stage, Clin Cancer Res, vol.12, pp.764-771, 2006.

H. Benlalam, N. Labarriere, B. Linard, L. Derre, E. Diez et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma inWltrating lymphocytes (TIL): implications for immunotherapy, Eur J Immunol, vol.31, pp.2007-2015, 2001.

H. Benlalam, B. Linard, Y. Guilloux, A. Moreau-aubry, L. Derre et al., IdentiWcation of Wve new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-inWltrating lymphocytes, J Immunol, vol.171, pp.6283-6289, 2003.

H. Benlalam, V. Vignard, A. Khammari, A. Bonnin, Y. Godet et al., Infusion of Melan-A/Mart-1 speciWc tumor-inWltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol Immunother, vol.56, pp.515-526, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-02482050

V. G. Brichard, J. Herman, A. Van-pel, C. Wildmann, B. Gaugler et al., A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes, Eur J Immunol, vol.26, pp.224-230, 1996.

C. Couedel, M. Bodinier, M. A. Peyrat, M. Bonneville, F. Davodeau et al., Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity, CD8 variable contribution compensating for diVerences in TCR aYnities, J Immunol, vol.162, pp.6351-6358, 1999.

P. G. Coulie, V. Brichard, A. Van-pel, T. Wolfel, J. Schneider et al., A new gene coding for a diVerentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J Exp Med, vol.180, pp.35-42, 1994.

E. De-plaen, C. Lurquin, B. Lethe, P. Van-der-bruggen, V. Brichard et al., IdentiWcation of genes coding for tumor antigens recognized by cytolytic T lymphocytes, Methods, vol.12, pp.125-142, 1997.

J. D. Domena, L. Johnston-dow, and P. Parham, The B*4002 allele encodes the B61 antigen: B40* is identical to B61, Tissue Antigens, vol.40, pp.254-256, 1992.

B. Dreno, J. M. Nguyen, A. Khammari, M. C. Pandolwno, M. H. Tessier et al., Randomized trial of adoptive transfer of melanoma tumor-inWltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol Immunother, vol.51, pp.539-546, 2002.

B. Gaugler, B. Van-den-eynde, P. Van-der-bruggen, P. Romero, J. J. Gaforio et al., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, J Exp Med, vol.179, pp.921-930, 1994.

N. Gervois, N. Labarriere, L. Guiner, S. Pandolwno, M. C. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are eYciently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin Cancer Res, vol.6, pp.1459-1467, 2000.

E. Godefroy, A. Moreau-aubry, E. Diez, B. Dreno, F. Jotereau et al., Alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen, J Exp Med, vol.202, pp.61-72, 2005.

Y. Guilloux, S. Lucas, V. G. Brichard, A. Van-pel, C. Viret et al., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J Exp Med, vol.183, pp.1173-1183, 1996.

T. Jung, U. Schauer, C. Heusser, C. Neumann, and C. Rieger, Detection of intracellular cytokines by Xow cytometry, J Immunol Methods, vol.159, pp.197-207, 1993.

X. Kang, Y. Kawakami, M. El-gamil, R. Wang, K. Sakaguchi et al., IdentiWcation of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-inWltrating lymphocytes, J Immunol, vol.155, pp.1343-1348, 1995.

Y. Kawakami, S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini et al., IdentiWcation of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor inWltrating lymphocytes, J Exp Med, vol.180, pp.347-352, 1994.

Y. Kawakami, P. F. Robbins, X. Wang, J. P. Tupesis, M. R. Parkhurst et al., IdentiWcation of new melanoma epitopes on melanosomal proteins recognized by tumor inWltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles, J Immunol, vol.161, pp.6985-6992, 1998.

D. J. Kittlesen, L. W. Thompson, P. H. Gulden, J. C. Skipper, T. A. Colella et al., Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development, J Immunol, vol.160, pp.2099-2106, 1998.

H. Kobayashi, T. Kokubo, M. Takahashi, K. Sato, N. Miyokawa et al., Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient, Immunogenetics, vol.47, pp.398-403, 1998.

N. Labarriere, M. C. Pandolwno, N. Gervois, A. Khammari, M. H. Tessier et al., Therapeutic eYcacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunol Immunother, vol.51, pp.532-538, 2002.

V. Lennerz, M. Fatho, C. Gentilini, R. A. Frye, A. Lifke et al., The response of autologous T cells to a human melanoma is dominated by mutated neoantigens, Proc Natl Acad Sci, vol.102, pp.16013-16018, 2005.

B. Linard, S. Bezieau, H. Benlalam, N. Labarriere, Y. Guilloux et al., A ras-mutated peptide targeted by CTL inWltrating a human melanoma lesion, J Immunol, vol.168, pp.4802-4808, 2002.

A. Moreau-aubry, L. Guiner, S. Labarriere, N. Gesnel, M. C. Jotereau et al., A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J Exp Med, vol.191, pp.1617-1624, 2000.

S. Morel, A. Ooms, A. Van-pel, T. Wolfel, V. G. Brichard et al., A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes, Int J Cancer, vol.83, pp.755-759, 1999.

C. Oserov, F. Kos, H. H. Bui, B. Peters, V. Pasquetto et al., HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation, Proc Natl Acad Sci, vol.102, pp.13980-13985, 2005.

M. C. Pandolwno, N. Labarriere, M. H. Tessier, A. Cassidanius, S. Bercegeay et al., Highscale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol Immunother, vol.50, pp.134-140, 2001.

H. G. Rammensee, T. Friede, and S. Stevanoviic, MHC ligands and peptide motifs: Wrst listing, Immunogenetics, vol.41, pp.178-228, 1995.

J. P. Riley, S. A. Rosenberg, and M. R. Parkhurst, IdentiWcation of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase, J Immunother, vol.24, pp.212-220, 2001.

L. Rowen, B. F. Koop, and L. Hood, The complete 685-kilobase DNA sequence of the human beta T cell receptor locus, Science, vol.272, pp.1755-1762, 1996.

E. Scotet, J. David-ameline, M. A. Peyrat, A. Moreau-aubry, D. Pinczon et al., T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis, J Exp Med, vol.184, pp.1791-1800, 1996.

J. Sidney, S. Southwood, V. Pasquetto, and A. Sette, Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype, J Immunol, vol.171, pp.5964-5974, 2003.

J. C. Skipper, R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van-pel et al., An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modiWcation and suggests a novel pathway for processing of membrane proteins, J Exp Med, vol.183, pp.527-534, 1996.

S. L. Topalian, M. I. Gonzales, M. Parkhurst, Y. F. Li, S. Southwood et al., Melanoma-speciWc CD4 + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes, J Exp Med, vol.183, pp.1965-1971, 1996.

C. Traversari, P. Van-der-bruggen, I. F. Luescher, C. Lurquin, P. Chomez et al., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E, J Exp Med, vol.176, pp.1453-1457, 1992.

D. Trivedi, R. Y. Williams, R. J. O'reilly, and G. Koehne, Generation of CMV-speciWc T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy, Blood, vol.105, pp.2793-2801, 2005.

T. Wolfel, A. Van-pel, V. Brichard, J. Schneider, B. Seliger et al., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes, Eur J Immunol, vol.24, pp.759-764, 1994.